Literature DB >> 11481684

Effect of sleep deprivation on motor performance in patients with Parkinson's disease.

B Högl1, C Peralta, T C Wetter, O Gershanik, C Trenkwalder.   

Abstract

Animal research provides evidence that sleep deprivation influences the dopamine system. Knowledge about the effect of sleep deprivation on motor performance in patients with Parkinsons disease is scarce. This study examines the influence of total and partial sleep deprivation compared to normal sleep on motor state and performance in Parkinson's disease. Fifteen nondepressed patients with Parkinson's disease underwent one night of total sleep deprivation (TSD), one night of partial sleep deprivation (PSD) after 3 a.m., and one control night of normal sleep (S), performed in a random, nonconsecutive order. Over a period of 3 hours the following morning, motor evaluations (United Parkinson's Disease Rating Scale, [UPDRS] and tapping rate) were performed before and every 30 minutes after intake of the usual morning dopaminergic drug dose. All patients underwent polysomnography apart from the sleep deprivation protocol. Mean UPDRS motor scores and tapping velocities did not differ significantly after each of the schedules, but a subgroup of four patients improved their motor score after partial sleep deprivation. These data do not confirm previous findings of an overall positive influence of sleep deprivation on motor function in Parkinson's disease. However, the results indicate that different response types to sleep deprivation may exist and that a subgroup of patients could benefit from partial sleep deprivation. Copyright 2001 Movement Disorder Society.

Entities:  

Mesh:

Year:  2001        PMID: 11481684     DOI: 10.1002/mds.1138

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  Levodopa availability improves with progression of Parkinson's disease.

Authors:  Dirk Woitalla; Oliver Goetze; Jeong I Kim; Alice B Nikodem; Wolfgang E Schmidt; Horst Przuntek; Thomas Müller
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

2.  Persistent short-term memory defects following sleep deprivation in a drosophila model of Parkinson disease.

Authors:  Laurent Seugnet; James E Galvin; Yasuko Suzuki; Laura Gottschalk; Paul J Shaw
Journal:  Sleep       Date:  2009-08       Impact factor: 5.849

3.  Sleep disturbances associated with Parkinson's disease.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Masaoki Iwanami; Koichi Hirata
Journal:  Parkinsons Dis       Date:  2011-08-17

4.  Synergistic anticataleptic effect of imipramine and nicotine in a rotenone-induced rat model.

Authors:  Ilya D Ionov; Irina I Pushinskaya; Nicholas P Gorev; Larissa A Shpilevaya
Journal:  Psychopharmacology (Berl)       Date:  2019-05-08       Impact factor: 4.415

Review 5.  Chronic sleep disturbance and neural injury: links to neurodegenerative disease.

Authors:  Sabra M Abbott; Aleksandar Videnovic
Journal:  Nat Sci Sleep       Date:  2016-01-25

Review 6.  The immunogenicity of midbrain dopaminergic neurons and the implications for neural grafting trials in Parkinson's disease.

Authors:  Shamma Qarin; Sarah K Howlett; Joanne L Jones; Roger A Barker
Journal:  Neuronal Signal       Date:  2021-09-13

7.  Objective Measurement and Characterization of Sleep Benefit in Parkinson's Disease.

Authors:  Will Lee; Andrew H Evans; David R Williams
Journal:  Mov Disord Clin Pract       Date:  2017-05-25

8.  Circadian and Homeostatic Modulation of Multi-Unit Activity in Midbrain Dopaminergic Structures.

Authors:  Karim Fifel; Johanna H Meijer; Tom Deboer
Journal:  Sci Rep       Date:  2018-05-17       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.